The physical characteristics, biocompatibility and safety profile of Phytospherix® makes it an ideal nanomaterial for use in biomedical applications. Glysantis’ R&D efforts are developing applications in diverse areas such as vaccine biomanufacturing, adjuvants, anti-infectives, oral health, antiinflammation and targeted drug delivery. Our scalable technology provides safe nanoparticles for a wide range of applications.